The Lasting Impact of Cytomegalovirus Education
June 29, 2023 | CMV, CMV Awareness Month, infectious disease, medical education
Education on the signs, symptoms, and potential complications of cytomegalovirus (CMV) is in need of constant development, as this common disease affects nearly 1 in 3 children by age 5 and over half of adults by age 40. New treatment options are being developed for patients at risk, including patients who have recently undergone organ transplantation, but these developments are not yet well-known among clinicians.
Recently, Medscape Education has sought to close these learning gaps by providing engaging education for infectious disease (ID) clinicians. This education has made a substantial impact, increasing knowledge and competence among clinicians and leading to publications at numerous conferences and congresses. Some of the poster presentations Medscape Education has given include:
- Critical Care Congress of the Society of Critical Care Medicine, February 2020, in Orlando, Florida (2 presentations)
- ID Week 2019, October 2019, in Washington, DC (4 presentations), and ID Week 2018, October 2018, in San Francisco, California (4 presentations)
- National Hemophilia Foundation annual meeting, October 2019, in Anaheim, California (2 presentations)
- Annual Congress of the European Hematology Association, June 2019, in Amsterdam (2 presentations)
- Annual Congress of the European Association for Haemophilia and Allied Disorders, February 2019, in Prague, Czech Republic (2 presentations)
- Annual Meeting and Exposition of the American Society of Hematology, December 2018, in San Diego, California (1 presentation)
One of the ways Medscape Education engages with learners is through symposia at medical meetings and congresses around the world. These symposia bring together leading faculty in infectious diseases, allowing them to share critical updates on the diagnosis, prevention, and management of CMV, and giving physician learners the opportunity to interact through polling questions, interactive slides, and Q&A with the faculty panelists.
The high visibility and quality of these events have attracted large numbers of learners, both in person at the conference and through virtual simulcasts of the event. This hybrid approach allows more physicians to be reached and expands the impact of the programs. Some recent symposia include:
- ID Week 2022 Symposium- Infectious Disease Specialist Perspectives on Cytomegalovirus Management in Transplant Patients: New Data and New Options
- American Transplant Congress (ATC) 2022 Symposium- Infectious Disease Specialist Perspectives on Cytomegalovirus Management in Transplant Patients: New Data and New Options
- Transplantation & Cellular Therapy (TCT) Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and Center for International Blood and Marrow Transplant Research (CIBMTR) 2023
Total Live-In Person & Virtual Participants: 1,400+
Medscape Education’s 25+ years of expertise in delivering quality education means that programs are positioned to reach the right audience at the right time, providing educational opportunities when learners need them and making them easily accessible. The table below shows activities focused on CVM in transplant patients, which has reached over 18,700+ learners.
|
Activity Title |
Launch Date |
|---|---|
|
Infectious Disease Specialist Perspectives on CMV Management in Transplant Patients: New Data and New Options |
11/16/2022 |
|
Integrating New Treatments and Individualizing Care in CMV Infection Post-Transplant |
6/22/2022 |
|
Managing Resistant/Refractory Cytomegalovirus Infection in Transplant Patients: Understanding the Drugs and the Data |
3/2/2022 |
Medscape Education ensures not only that education reaches the right learners, but that it is designed with clinical learning goals in mind and makes a significant impact on clinicians.
Among clinicians who participated in one of Medscape’s recent CMV and transplantation educational activities, Challenges and Opportunities in the Transplant Patient: Focus on Improving Care for CMV Infection, survey respondents who saw an average of 7 patients with CMV per month reported that the activity prompted them to make a number of changes1:
87% of participants modified or implemented a new practice or had their practice reinforced due to education, by:
- Incorporating new agents into practice for the treatment of resistant/refractory CMV based on current data (68%)
- Implementing a management strategy for resistant or refractory CMV (67%)
- Collaborating with health system plans and primary payers to update and adopt reimbursement criteria early (64%)
Data from 2 additional programs indicated that1:
- 44% of clinicians increased their knowledge and competence about the mechanism of action of CMV treatments
- 43% increased their knowledge and competence about clinical trial data
- 22% increased their ability to select or individualize CMV treatments based on individual patient characteristics and guidelines
In the future, Medscape Education will continue to develop education focused on closing learning gaps in CMV in order to improve outcomes for patients everywhere.
For more information on CMV education at Medscape Education, please contact Jovana Lubarda at JLubarda@medscape.net or Jess Dropkin at JDropkin@medscape.net
1Medscape Internal Data March 2022.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Women in Healthcare Leadership Have a Lot to Say. Medscape’s Hear From Her Wins an APEX Grand Award.
Medscape Education has been honoured with the prestigious APEX Grand Award for Publication Excellence at...
Moving Beyond the 10%: A New Era in Preterm Birth Prevention
For decades, the rate of spontaneous preterm birth in the United States has hovered stubbornly around 10%. Despite advancements in other areas of medicine, prematurity remains the second leading cause...
Medscape Education to Showcase the Impact of Neurology CME at EAN 2026
Medscape Education, the leading global provider of continuing medical education (CME), has announced its agenda for the upcoming 12th Congress of the European Academy of Neurology (EAN) 2026 in Geneva,...
Medscape Education Recognized With 2 Spring 2026 Digital Health Awards for Excellence in Clinical Education
Medscape Education has been recognized with 2 prestigious accolades at the Spring 2026 Digital Health Awards. The premier digital education platform earned a Gold Award for its PIONEER initiative in...
Medscape Education Brings AI to the Hematology Frontline at EHA 2026
Medscape Education is supporting a dedicated AI symposium at the 2026 European Hematology Association (EHA) Annual Congress in Stockholm on June 11, 2026.
The Ripple Effect: Why Connection is the Heart of Healthcare Leadership
In the fast-paced environment of clinical medicine, it is easy to focus solely on data and outcomes. However, as Dr. Toyin Nwafor (Gilead Sciences) and Dr. Shirin Mazumder (University of...
Beyond the Nudge: Why Mentorship is the New Healthcare Currency
In the latest episode of Hear From Her, the conversation centers on a striking reality: women in healthcare often face a "confidence gap" that their male counterparts do not. While...
Three Symposia, Three Years of Fellows, One Mission: Medscape Oncology at ASCO 2026
Three symposia. A third year of Fellows. AI live on the booth floor. Medscape Oncology arrives at ASCO 2026 (Booth #10099) with another ambitious oncology program.
How Sweet It Is: Medscape at ADA 2026
The energy is building as we prepare to head to New Orleans, LA, for the annual scientific sessions of the American Diabetes Association from June 4-8. The Medscape Diabetes and...
Keep the Beat Going: Education and Impact at the European Society of Cardiology Heart Failure Congress 2026
Did you know? Over 320,000 learners have engaged with heart failure content on Medscape. With such an enthusiastic audience for our education, we’re thrilled to be joining cardiology professionals from...